Gerresheimer (ETR:GXI) has been assigned a €81.00 ($94.19) price objective by research analysts at Berenberg Bank in a research report issued to clients and investors on Thursday, Borsen Zeitung reports. The brokerage currently has a “buy” rating on the stock. Berenberg Bank’s price objective would indicate a potential upside of 25.87% from the stock’s current price.
A number of other brokerages have also recently issued reports on GXI. JPMorgan Chase & Co. set a €56.40 ($65.58) target price on Gerresheimer and gave the stock a “sell” rating in a report on Monday, October 7th. Deutsche Bank set a €83.00 ($96.51) target price on Gerresheimer and gave the stock a “buy” rating in a report on Monday, October 7th. Hauck & Aufhaeuser set a €50.00 ($58.14) price target on Gerresheimer and gave the company a “sell” rating in a research note on Friday, July 12th. Goldman Sachs Group set a €65.00 ($75.58) price target on Gerresheimer and gave the company a “neutral” rating in a research note on Thursday. Finally, DZ Bank reissued a “neutral” rating on shares of Gerresheimer in a research note on Thursday, July 11th. Three investment analysts have rated the stock with a sell rating, three have issued a hold rating and four have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of €72.16 ($83.90).
Shares of GXI opened at €64.35 ($74.83) on Thursday. Gerresheimer has a 12-month low of €51.10 ($59.42) and a 12-month high of €74.80 ($86.98). The business has a 50-day simple moving average of €66.93 and a two-hundred day simple moving average of €67.48. The company has a quick ratio of 0.56, a current ratio of 0.85 and a debt-to-equity ratio of 64.56. The stock has a market cap of $2.02 billion and a PE ratio of 9.76.
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through three divisions; Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Featured Story: What does a bar chart mean for investors?
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.